Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review
Colorectal cancer (CRC) is a common, and deadly disease. Despite the improved knowledge on CRC heterogeneity and advances in the medical sciences, there is still an urgent need to cope with the challenges and side effects of common treatments for the disease. Natural products (NPs) have always been...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-07-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.929161/full |
| _version_ | 1818156526460731392 |
|---|---|
| author | Yadollah Bahrami Yadollah Bahrami Yadollah Bahrami Sasan Bouk Elham Kakaei Mohammad Taheri Mohammad Taheri |
| author_facet | Yadollah Bahrami Yadollah Bahrami Yadollah Bahrami Sasan Bouk Elham Kakaei Mohammad Taheri Mohammad Taheri |
| author_sort | Yadollah Bahrami |
| collection | DOAJ |
| description | Colorectal cancer (CRC) is a common, and deadly disease. Despite the improved knowledge on CRC heterogeneity and advances in the medical sciences, there is still an urgent need to cope with the challenges and side effects of common treatments for the disease. Natural products (NPs) have always been of interest for the development of new medicines. Actinobacteria are known to be prolific producers of a wide range of bioactive NPs, and scientific evidence highlights their important protective role against CRC. This review is a holistic picture on actinobacter-derived cytotoxic compounds against CRC that provides a good perspective for drug development and design in near future. This review also describes the chemical structure of 232 NPs presenting anti-CRC activity with the being majority of quinones, lactones, alkaloids, peptides, and glycosides. The study reveals that most of these NPs are derived from marine actinobacteria followed by terrestrial and endophytic actinobacteria, respectively. They are predominantly produced by Streptomyces, Micromonospors, Saliniospors and Actinomadura, respectively, in which Streptomyces, as the predominant contributor generating over 76% of compounds exclusively. Besides it provides a valuable snapshot of the chemical structure-activity relationship of compounds, highlighting the presence or absence of some specific atoms and chemical units in the structure of compounds can greatly influence their biological activities. To the best of our knowledge, this is the first comprehensive review on natural actinobacterial compounds affecting different types of CRC. Our study reveals that the high diversity of actinobacterial strains and their NPs derivatives, described here provides a new perspective and direction for the production of new anti-CRC drugs and paves the way to innovation for drugs discovery in the future. The knowledge obtain from this review can help us to understand the pivotal application of actinobacteria in future drugs development. |
| first_indexed | 2024-12-11T14:59:42Z |
| format | Article |
| id | doaj.art-83a89f0c09f3401f9e7197dd629a943f |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-11T14:59:42Z |
| publishDate | 2022-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-83a89f0c09f3401f9e7197dd629a943f2022-12-22T01:01:12ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-07-011310.3389/fphar.2022.929161929161Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A ReviewYadollah Bahrami0Yadollah Bahrami1Yadollah Bahrami2Sasan Bouk3Elham Kakaei4Mohammad Taheri5Mohammad Taheri6Department of Medical Biotechnology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranPharmaceutical Research Center, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Medical Biotechnology, School of Medicine, College of Medicine and Public Health, Flinders University, Adelaide, SA, AustraliaDepartment of Medical Biotechnology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranDepartment of Medical Biotechnology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, IranInstitute of Human Genetics, University Hospital Jena, Jena, GermanyUrology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranColorectal cancer (CRC) is a common, and deadly disease. Despite the improved knowledge on CRC heterogeneity and advances in the medical sciences, there is still an urgent need to cope with the challenges and side effects of common treatments for the disease. Natural products (NPs) have always been of interest for the development of new medicines. Actinobacteria are known to be prolific producers of a wide range of bioactive NPs, and scientific evidence highlights their important protective role against CRC. This review is a holistic picture on actinobacter-derived cytotoxic compounds against CRC that provides a good perspective for drug development and design in near future. This review also describes the chemical structure of 232 NPs presenting anti-CRC activity with the being majority of quinones, lactones, alkaloids, peptides, and glycosides. The study reveals that most of these NPs are derived from marine actinobacteria followed by terrestrial and endophytic actinobacteria, respectively. They are predominantly produced by Streptomyces, Micromonospors, Saliniospors and Actinomadura, respectively, in which Streptomyces, as the predominant contributor generating over 76% of compounds exclusively. Besides it provides a valuable snapshot of the chemical structure-activity relationship of compounds, highlighting the presence or absence of some specific atoms and chemical units in the structure of compounds can greatly influence their biological activities. To the best of our knowledge, this is the first comprehensive review on natural actinobacterial compounds affecting different types of CRC. Our study reveals that the high diversity of actinobacterial strains and their NPs derivatives, described here provides a new perspective and direction for the production of new anti-CRC drugs and paves the way to innovation for drugs discovery in the future. The knowledge obtain from this review can help us to understand the pivotal application of actinobacteria in future drugs development.https://www.frontiersin.org/articles/10.3389/fphar.2022.929161/fullcolorectal cancernatural productsactinobacteriasecondary metabolitesanti-cancer effectsmarine actinobacteria |
| spellingShingle | Yadollah Bahrami Yadollah Bahrami Yadollah Bahrami Sasan Bouk Elham Kakaei Mohammad Taheri Mohammad Taheri Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review Frontiers in Pharmacology colorectal cancer natural products actinobacteria secondary metabolites anti-cancer effects marine actinobacteria |
| title | Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review |
| title_full | Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review |
| title_fullStr | Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review |
| title_full_unstemmed | Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review |
| title_short | Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review |
| title_sort | natural products from actinobacteria as a potential source of new therapies against colorectal cancer a review |
| topic | colorectal cancer natural products actinobacteria secondary metabolites anti-cancer effects marine actinobacteria |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.929161/full |
| work_keys_str_mv | AT yadollahbahrami naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT yadollahbahrami naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT yadollahbahrami naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT sasanbouk naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT elhamkakaei naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT mohammadtaheri naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview AT mohammadtaheri naturalproductsfromactinobacteriaasapotentialsourceofnewtherapiesagainstcolorectalcancerareview |